BETA
Early release — we are building new features fast, you may encounter issues. Help us improve:
contact us
to report bugs or share feedback.
✕
Loading...
Analytics
Equity Analytics
On the record this week: what the Street published, what insiders filed, and what reports next.
←
Back to Equity Analytics
Equity Analytics
/
KVUE
KVUE
Kenvue Inc.
Consumer Defensive - US
Kenvue Inc. Kenvue Inc. (KVUE) operates as the world's largest pure-play consumer health company by revenue, focusing on science-backed everyday care products that serve over 1.2 billion people daily across more than 100 countries including…
Show more
HQ: Summit, NJ, United States of America
www.kenvue.com
USD
17.78
-0.06%
vs prev. close
Overview
Fundamentals
Ownership & Activity
Analyst Consensus
Seasonality & Patterns
News
Research
Market snapshot
Price
USD
17.78
Daily move
-0.06%
P/E
20.9
EPS TTM
0.85
Dividend yield
4.72%
Beta
0.43
Market cap
34.2B
Price history
KVUE price
USD
Line
Candle
Volume
Log scale
1m
3m
6m
1y
3y
5y
10y
max
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Valuation & performance
Risk
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Kenvue
KVUE
Household & Personal Products
34.2
20.9
4.72%
-5.1%
-6.3%
-2.0%
+1.7%
-5.7%
+3.1%
🔒
Subscribe to Equity Analytics to compare KVUE with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.
View plans
Ask Ashenden
One question, one concise answer grounded in Ashenden research.
Ask
Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.
Is KVUE cheap or expensive against its peers, and what justifies the gap?
What does the price already assume about KVUE?
What would have to go wrong for KVUE from here?
Why KVUE now, and not a year ago?